1. Home
  2. BIO vs EXLS Comparison

BIO vs EXLS Comparison

Compare BIO & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • EXLS
  • Stock Information
  • Founded
  • BIO 1952
  • EXLS 1999
  • Country
  • BIO United States
  • EXLS United States
  • Employees
  • BIO N/A
  • EXLS N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • EXLS Business Services
  • Sector
  • BIO Industrials
  • EXLS Consumer Discretionary
  • Exchange
  • BIO Nasdaq
  • EXLS Nasdaq
  • Market Cap
  • BIO 6.6B
  • EXLS 7.3B
  • IPO Year
  • BIO N/A
  • EXLS 2006
  • Fundamental
  • Price
  • BIO $264.53
  • EXLS $42.13
  • Analyst Decision
  • BIO Strong Buy
  • EXLS Strong Buy
  • Analyst Count
  • BIO 4
  • EXLS 6
  • Target Price
  • BIO $333.50
  • EXLS $51.50
  • AVG Volume (30 Days)
  • BIO 342.3K
  • EXLS 1.9M
  • Earning Date
  • BIO 07-31-2025
  • EXLS 07-29-2025
  • Dividend Yield
  • BIO N/A
  • EXLS N/A
  • EPS Growth
  • BIO N/A
  • EXLS 34.45
  • EPS
  • BIO 11.49
  • EXLS 1.45
  • Revenue
  • BIO $2,554,200,000.00
  • EXLS $1,968,978,000.00
  • Revenue This Year
  • BIO N/A
  • EXLS $14.23
  • Revenue Next Year
  • BIO $3.42
  • EXLS $11.43
  • P/E Ratio
  • BIO $22.99
  • EXLS $28.98
  • Revenue Growth
  • BIO N/A
  • EXLS 15.15
  • 52 Week Low
  • BIO $211.43
  • EXLS $33.96
  • 52 Week High
  • BIO $387.99
  • EXLS $52.43
  • Technical
  • Relative Strength Index (RSI)
  • BIO 55.27
  • EXLS 42.96
  • Support Level
  • BIO $261.65
  • EXLS $41.93
  • Resistance Level
  • BIO $270.71
  • EXLS $42.84
  • Average True Range (ATR)
  • BIO 8.66
  • EXLS 1.07
  • MACD
  • BIO -0.13
  • EXLS 0.05
  • Stochastic Oscillator
  • BIO 46.22
  • EXLS 4.41

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

Share on Social Networks: